Back
ZyVersa Therapeutics Stock Price Chart

Your Portfolio's Boring. This Company Isn't And It's Early
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio
Sell
20
ZVSA
ZyVersa Therapeutics
Last Price:
$0.54
Seasonality Move:
-29.61%
7 Day Trial
ALL ACCESS PASS
$
7

This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio-
The current trend is relatively stagnant and ZVSA is experiencing buying pressure, which is a positive indicator for future bullish movement.
ZyVersa Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.53 | Buy |
20-day SMA: | 0.59 | Sell |
50-day SMA: | 0.68 | Sell |
200-day SMA: | 1.51 | Sell |
8-day EMA: | 0.54 | Buy |
20-day EMA: | 0.59 | Sell |
50-day EMA: | 0.71 | Sell |
200-day EMA: | 13.08 | Sell |
ZyVersa Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 43.37 | Sell |
Chaikin Money Flow: | 110792 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.53 - 0.69) | Sell |
Bollinger Bands (100): | (0.65 - 1.27) | Sell |
ZyVersa Therapeutics Technical Analysis
May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for ZyVersa Therapeutics Stock
Is ZyVersa Therapeutics Stock a Buy?
-
ZyVersa Therapeutics share price is 0.55 while ZVSA 8-day simple moving average is 0.53, which is a Buy signal.
-
The stock price of ZVSA is 0.55 while ZyVersa Therapeutics 20-day SMA is 0.59, which makes it a Sell.
-
ZyVersa Therapeutics 50-day simple moving average is 0.68 while ZVSA share price is 0.55, making it a Sell technically.
-
ZVSA stock price is 0.55 and ZyVersa Therapeutics 200-day simple moving average is 1.51, creating a Sell signal.
ZVSA Technical Analysis vs Fundamental Analysis
Sell
20
ZyVersa Therapeutics (ZVSA)
is a Sell
Is ZyVersa Therapeutics a Buy or a Sell?
-
ZyVersa Therapeutics stock is rated a SellThe current ZyVersa Therapeutics [ZVSA] share price is $0.55. The Score for ZVSA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
ZyVersa Therapeutics Stock Info
Market Cap:
2.6M
Price in USD:
0.55
Share Volume:
110.8K
ZyVersa Therapeutics 52-Week Range
52-Week High:
6.30
52-Week Low:
0.47
Sell
20
ZyVersa Therapeutics (ZVSA)
is a Sell
ZyVersa Therapeutics Share Price Forecast
-
What is the ZyVersa Therapeutics stock price today?The ZyVersa Therapeutics stock price is 0.55 USD today.
-
Will ZVSA stock go up or go down?ZyVersa Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is ZyVersa Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ZyVersa Therapeutics is overvalued.
Is ZyVersa Therapeutics Stock a Buy?
-
ZyVersa Therapeutics share price is 0.55 while ZVSA 8-day exponential moving average is 0.54, which is a Buy signal.
-
The stock price of ZVSA is 0.55 while ZyVersa Therapeutics 20-day EMA is 0.59, which makes it a Sell.
-
ZyVersa Therapeutics 50-day exponential moving average is 0.71 while ZVSA share price is 0.55, making it a Sell technically.
-
ZVSA stock price is 0.55 and ZyVersa Therapeutics 200-day simple moving average is 13.08, creating a Sell signal.
Fundamental Analysis of ZyVersa Therapeutics
Is ZyVersa Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $1.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $11.20 per share, and a decrease next year of $0.00 per share.
Technical Analysis of ZyVersa Therapeutics
Should I short ZyVersa Therapeutics stock?
-
ZVSA Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting ZyVersa Therapeutics is a Sell
-
ZyVersa Therapeutics Relative Strength Index (RSI) is 43.37, which suggest ZyVersa Therapeutics is oversold
-
The Bollinger Bands (25) for ZyVersa Therapeutics is (0.53 - 0.69), which suggest ZyVersa Therapeutics is a Sell
-
The Bollinger Bands (100) for ZyVersa Therapeutics is (0.65 - 1.27), which suggest ZyVersa Therapeutics is a Sell
* ZyVersa Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.